MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...
EQUATE acute graft-versus host disease (aGVHD) study observed rapid response and durability through day 85 EQUATE aGVHD study reported a clinically...
Trial Initiation Anticipated in Second Quarter 2021 $2M Grant Awarded by the Department of Defense in September 2020 to Support...
Vitiligo Repigmentation Achieved in Five Treatments with XTRAC® Excimer Laser HORSHAM, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN)...
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
SAN CARLOS, Calif., March 15, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions...
PRESS RELEASE March 15, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that...
CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic...
Jeff Bornstein, M.D. to serve as Chief Medical Officer and Paul Little as Chief Financial OfficerIRVINE, Calif., March 15, 2021...
The Journal of Medical Economics shows that implementing Wellframe reduced inpatient admissions by 17%BOSTON, March 15, 2021 (GLOBE NEWSWIRE) --...
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development...
MARKHAM, Ontario, March 15, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Oryzon will consequently proceed to file an IND applicationPORTICO will be developed in several US and European sites MADRID, Spain...
-- BMB compound significantly reduced fentanyl intake in an animal model of opioid abuse -- -- Potential to reduce continued...
2020 Revenues Increase Over 330% Year-over-Year to Record $3.2 Million Murata Confirms XBAR® Performance and Moves Into Manufacturing Development Phase...
Announced signing of transaction transferring Ovid’s 50% of global rights to develop and commercialize soticlestat (TAK-935/OV935) to Takeda, under which...
MONTREAL, March 15, 2021 (GLOBE NEWSWIRE) -- Semeon Analytics, an ATW Tech Inc. company, and Adexflow international are joining forces...
Novel UCSF investigator led Phase 2 clinical study to address role of epigenetic therapy in mitigating resistance to immune-oncology drugsCALGARY,...
SAINT LAURENT, Quebec, and NEW YORK, March 15, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (the “Corporation”) today...
Data provides first-in-patient mechanistic proof-of-concept for ATYR1923. ATYR1923 reduced key inflammatory cytokines that are implicated in sarcoidosis and other ILDs,...